VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zebra 365 who wrote (4726)	1/18/1998 11:19:00 AM
From: Frostman	Read Replies (1) of 23519

This on WSJ electronic; interesting perspective. Drugs for the Asian flu! <g> Go VVUS! Frostman January 19, 1998 Prescription For Profit? Major drug stocks rose an average of 48% in 1997, handily outpacing the S&P 500, and they're beating the market so far in 1998. Salomon Smith Barney's drug analyst, Christina Heuer, believes the drugs will continue to fare well this year, driven by new products and strong profit gains. Profits* Company Price 52-week 1997 1998 P/E** Gain Bristol-Myers Squibb 92 59% $3.21 $3.70 25 Eli Lilly 67 72 1.61 2.00 34 Merck 108 3/4 34 3.80 4.35 25 Pfizer 76 77 1.70 2.00 38 Warner-Lambert 127 66 3.20 4.20 30 Schering-Plough 68 99 1.95 2.30 30 Salomon Smith Barney estimates. *Based on 1998 estimates.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next